Related Experiment Video
Updated: Jun 22, 2026
05:19
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Palliative prostate radiotherapy for symptomatic advanced prostate cancer
Omar S Din1, Narottam Thanvi, Catherine J Ferguson
1Department of Clinical Oncology, Weston Park Hospital, Sheffield, UK. o.din@sheffield.ac.uk
Summary
Short-course palliative radiotherapy effectively manages localized prostate cancer symptoms with minimal side effects. This treatment offers significant symptom relief for advanced prostate carcinoma patients.
Area of Science:
- Oncology
- Radiation Oncology
- Palliative Care
Background:
- Advanced prostate carcinoma presents significant challenges in symptom management.
- Palliative radiotherapy is explored for localized symptom relief.
Purpose of the Study:
- To evaluate the efficacy of short-course palliative radiotherapy for localized prostate cancer symptoms.
- To assess treatment response and toxicity.
Main Methods:
- Retrospective analysis of 58 patients treated between 2003-2007.
- Data collected on demographics, radiotherapy details, and symptom/toxicity scores.
- Standardized scoring scale used for symptom and toxicity assessment.
Main Results:
- 89% of patients experienced complete or partial symptom resolution at 4 months.
- Effective palliation observed for rectal symptoms (75%), pelvic pain (69%), urinary obstruction (54%), and hematuria (42%).
- Mild to moderate, self-limiting toxicity reported.
Conclusions:
- Short-course palliative radiotherapy is an effective palliative option for prostate cancer local symptoms.
- The treatment demonstrates a favorable toxicity profile.
- Further prospective studies are recommended for detailed benefit assessment.
